NCT05084196View on ClinicalTrials.gov

Melatonin for Prevention of Kidney Injury

PHASE3RecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

June 5, 2023

Primary Completion Date

June 1, 2026

Study Completion Date

December 31, 2026

Conditions
Acute Kidney InjuryAdverse Drug Event
Interventions
DRUG

Melatonin

Melatonin 5 mg capsule by mouth at bedtime

OTHER

Placebo Capsule

Placebo capsule by mouth at bedtime

Trial Locations (2)

08901

RECRUITING

Robert Wood Johnson University Hospital, New Brunswick

08876

RECRUITING

Robert Wood Johnson University Hospital Somerset, Somerville

All Listed Sponsors
lead

Rutgers, The State University of New Jersey

OTHER